Skip to main content
. 2018 Jul 26;13(7):e0200936. doi: 10.1371/journal.pone.0200936

Fig 1. Kaplan-Meier analyses for disease-specific survival of all 661 patients with breast cancer according to the preoperative systemic inflammatory markers.

Fig 1

An elevated neutrophil-lymphocyte ratio (NLR) (A), derived neutrophil-lymphocyte ratio (dNLR) (B), and platelet-lymphocyte ratio (PLR) (C) predicted poor disease-specific survival following surgical resection. A low lymphocyte-monocyte ratio (LMR) (D) predicted poor disease-specific survival.